celecoxib has been researched along with Histoplasmosis in 1 studies
Histoplasmosis: Infection resulting from exposure to the fungus HISTOPLASMA. It is worldwide in distribution and particularly common in the central and eastern states, especially areas around the Ohio and Mississippi River valleys.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Therefore, using a pharmacological inhibitor, celecoxib, we investigated the role of prostaglandins in host defense against Histoplasma capsulatum infection in C57BL/6 mice." | 7.79 | Celecoxib improves host defense through prostaglandin inhibition during Histoplasma capsulatum infection. ( Bitencourt, Cda S; Faccioli, LH; Nicolete, R; Pereira, PA; Peres-Buzalaf, C; Ramos, SG; Sadikot, R; Secatto, A; Trindade, BC, 2013) |
| " Therefore, using a pharmacological inhibitor, celecoxib, we investigated the role of prostaglandins in host defense against Histoplasma capsulatum infection in C57BL/6 mice." | 3.79 | Celecoxib improves host defense through prostaglandin inhibition during Histoplasma capsulatum infection. ( Bitencourt, Cda S; Faccioli, LH; Nicolete, R; Pereira, PA; Peres-Buzalaf, C; Ramos, SG; Sadikot, R; Secatto, A; Trindade, BC, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pereira, PA | 1 |
| Trindade, BC | 1 |
| Secatto, A | 1 |
| Nicolete, R | 1 |
| Peres-Buzalaf, C | 1 |
| Ramos, SG | 1 |
| Sadikot, R | 1 |
| Bitencourt, Cda S | 1 |
| Faccioli, LH | 1 |
1 other study available for celecoxib and Histoplasmosis
| Article | Year |
|---|---|
Celecoxib improves host defense through prostaglandin inhibition during Histoplasma capsulatum infection.
Topics: Animals; Celecoxib; Cyclooxygenase 2 Inhibitors; Histoplasma; Histoplasmosis; Interferon-gamma; Leuk | 2013 |